Cohen Eric P, Hankey Kim G, Bennett Alexander W, Farese Ann M, Parker George A, MacVittie Thomas J
Departments of a Medicine and.
b Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland; and.
Radiat Res. 2017 Dec;188(6):661-671. doi: 10.1667/RR24857.1. Epub 2017 Oct 16.
The development of medical countermeasures against acute and delayed multi-organ injury requires animal models predictive of the human response to radiation and its treatment. Late chronic injury is a well-known feature of radiation nephropathy, but acute kidney injury has not been reported in an appropriate animal model. We have established a single-fraction partial-body irradiation model with minimal marrow sparing in non-human primates. Subject-based medical management was used including parenteral fluids according to prospective morbidity criteria. We show herein that 10 or 11 Gy exposures caused both acute and chronic kidney injury. Acute and chronic kidney injury appear to be dose-independent between 10 and 11 Gy. Acute kidney injury was identified during the first 50 days postirradiation and appeared to resolve before the occurrence of chronic kidney injury, which was progressively more severe up to 180 days postirradiation, which was the end of the study. These findings show that mitigation of the acute radiation syndrome by medical management will unmask delayed late effects that occur months after partial-body irradiation. They further emphasize that both acute and chronic changes in kidney function must be taken into account in the use and timing of mitigators and medical management for acute radiation syndrome and delayed effects of acute radiation exposure (DEARE).
针对急性和迟发性多器官损伤研发医学应对措施需要能够预测人类对辐射及其治疗反应的动物模型。晚期慢性损伤是放射性肾病的一个众所周知的特征,但在合适的动物模型中尚未报道过急性肾损伤。我们在非人灵长类动物中建立了一种单剂量局部身体照射模型,对骨髓的 sparing 最小。采用基于个体的医疗管理,包括根据前瞻性发病标准给予肠胃外补液。我们在此表明,10 或 11 Gy 的照射剂量会导致急性和慢性肾损伤。急性和慢性肾损伤在 10 至 11 Gy 之间似乎与剂量无关。急性肾损伤在照射后前 50 天内被识别出来,并且似乎在慢性肾损伤出现之前就已缓解,慢性肾损伤在照射后 180 天(即研究结束时)逐渐加重。这些发现表明,通过医疗管理减轻急性放射综合征会揭示局部身体照射数月后出现的延迟晚期效应。它们进一步强调,在使用缓解剂以及对急性放射综合征和急性辐射暴露延迟效应(DEARE)进行医疗管理的时机方面,必须同时考虑肾功能的急性和慢性变化。